Home / Private raises / Potentiam Biosciences, Inc.
Potentiam Biosciences, Inc.
Biotechnology · Irving, Texas · $250K sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | D (new) | $250K | Open-ended | 1 | 506(b) | Options/warrants, Security to be acquired, Simple Agreement for Future Equity (SAFE) | Nov 3 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Issuer
| Industry | Biotechnology |
| Located | Irving, Texas |
| Entity | Corporation |
| Incorporated | Delaware, 2024 |
| Minimum investment | $1 |
| SEC CIK | 2164266 |
People named in the latest filing
| Name | Role |
|---|---|
| Bruce Alan Beutler | Sole Director; Chairman, President and Secretary |
| Peppi Prasit | Chief Executive Officer |
| Xinzhu Wang | Treasurer |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
